'So it's real': fibromyalgia, diagnostic injustice, and the case for a shared system response.

Fibromyalgia affects 2-4.5% of the UK population, yet remains among the most poorly recognised and inequitably managed conditions in primary and secondary care. Diagnostic delay averages six years with direct clinical and economic consequences, compounded by persistent stigma rooted in historical scepticism of patients' symptomatology. Recent guidance from the RCP, BSR, GIRFT, and NICE has sought to improve diagnostic clarity and management pathways, yet implementation remains inconsistent and fragmented across England. Current referral arrangements and service provision create institutional barriers that fall disproportionately on patients in deprived areas. This paper examines these systemic failures and argues for a coordinated, multi-level response spanning diagnostic confidence in primary care, specialist consultation as a clinical intervention, equitable access to pain services, and workforce training reform. The goal is not specialist ownership, but integrated contribution from every part of the healthcare pathway.